1 Min Read
* PROMORE PHARMA SIGNS OUT-LICENSING AGREEMENT WITH TRANSDERMAL THERAPEUTIC TECHNOLOGIES FOR ITS PEPTIDE DPK-060 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.